|
Thursday, July 12, 2001 |
|
Optimizing Outcomes
after
Liver Transplantation
Room: Potsdam I |
|
07:30 - 08:45
|
Chairs:
John Lake, Minneapolis
Peter Neuhaus, Berlin |
|
07:30
|
Welcome and introductions
John Lake, Minneapolis
|
|
07:40
|
The role of new interferons in the pre- and post- transplant management
of hepatitis C
Michael Fried, Chapel Hill
|
|
07:55
|
Does mycophenolate mofetil (MMF) delay the progression of hepatitis
(after liver transplantation)?
Carlos Fasola, Dallas
|
|
08:10
|
Calcineurin inhibitor sparing/withdrawal regimens after liver transplantation
Nigel Heaton, London
|
|
08:25
|
Questions & Answers / Conclusions
Chairs and Faculty
|
|
This symposium is sponsored by an unrestricted educational grant from F.
Hoffmann-La Roche Ltd.
|